• Something wrong with this record ?

Results of retrospective classification of thyroid FNAs according to the Bethesda system: would this have improved accuracy

L. Srbova, F. Gabalec, A. Ryska, J. Cap,

. 2015 ; 26 (4) : 231-7. [pub] 20140730

Language English Country England, Great Britain

Document type Journal Article

OBJECTIVES: To retrospectively reclassify the results of fine needle aspiration (FNA) cytology at our institution according to the Bethesda system for reporting thyroid cytopathology (TBSRTC), and to determine whether the introduction of the new classification system would have influenced the diagnostic accuracy compared with our existing system in which suspicious/indeterminate categories (categories III-IV) are managed according to clinical findings and cytopathologists' recommendations. METHODS: FNAs performed under ultrasound guidance between 2001 and 2012, and subsequently verified by histology or repeat FNA and follow-up, were reviewed and retrospectively reclassified according to TBSRTC. RESULTS: Among a total of 1310 histologically verified FNAs, the positive predictive values (%) for malignancy and neoplasia (carcinoma + follicular adenomas) for category I-VI according to the TBSRTC were 5.7/11.3, 2.6/5.5, 14.4/34.2, 23.6/55.0, 57.0/64.5 and 92.2/94.2, respectively. Although all the categories predict malignancy closely, the difference in malignancy rate between categories III and IV was not statistically significant; however, the difference in total neoplasia rate reached statistical significance. When patients with cytological and clinical follow-up were included, the malignancy rated dropped in category I to 2.4%, whereas, in category III, it remained at 13%. Repeat FNA instead of direct surgery spared half of the patients from surgery. The cytopathologists' recommendations for histological verification in category III were associated with an insignificant increase in malignancy rate, but the total neoplasia rate reached 57.5%. CONCLUSIONS: At our institution, the application of the TBSRTC did not improve the diagnostic accuracy for the detection of malignancy compared with current practice. In selected cases with cytological results falling into category III (according to clinical data and cytopathologists' opinions), direct lobectomy seems to be justified.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16021078
003      
CZ-PrNML
005      
20160725114001.0
007      
ta
008      
160722s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/cyt.12171 $2 doi
024    7_
$a 10.1111/cyt.12171 $2 doi
035    __
$a (PubMed)25077794
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Srbova, L $u Department of Clinical Endocrinology, The Institute of Endocrinology, Prague, Czech Republic.
245    10
$a Results of retrospective classification of thyroid FNAs according to the Bethesda system: would this have improved accuracy / $c L. Srbova, F. Gabalec, A. Ryska, J. Cap,
520    9_
$a OBJECTIVES: To retrospectively reclassify the results of fine needle aspiration (FNA) cytology at our institution according to the Bethesda system for reporting thyroid cytopathology (TBSRTC), and to determine whether the introduction of the new classification system would have influenced the diagnostic accuracy compared with our existing system in which suspicious/indeterminate categories (categories III-IV) are managed according to clinical findings and cytopathologists' recommendations. METHODS: FNAs performed under ultrasound guidance between 2001 and 2012, and subsequently verified by histology or repeat FNA and follow-up, were reviewed and retrospectively reclassified according to TBSRTC. RESULTS: Among a total of 1310 histologically verified FNAs, the positive predictive values (%) for malignancy and neoplasia (carcinoma + follicular adenomas) for category I-VI according to the TBSRTC were 5.7/11.3, 2.6/5.5, 14.4/34.2, 23.6/55.0, 57.0/64.5 and 92.2/94.2, respectively. Although all the categories predict malignancy closely, the difference in malignancy rate between categories III and IV was not statistically significant; however, the difference in total neoplasia rate reached statistical significance. When patients with cytological and clinical follow-up were included, the malignancy rated dropped in category I to 2.4%, whereas, in category III, it remained at 13%. Repeat FNA instead of direct surgery spared half of the patients from surgery. The cytopathologists' recommendations for histological verification in category III were associated with an insignificant increase in malignancy rate, but the total neoplasia rate reached 57.5%. CONCLUSIONS: At our institution, the application of the TBSRTC did not improve the diagnostic accuracy for the detection of malignancy compared with current practice. In selected cases with cytological results falling into category III (according to clinical data and cytopathologists' opinions), direct lobectomy seems to be justified.
650    _2
$a tenkojehlová biopsie $x metody $7 D044963
650    _2
$a cytodiagnostika $x metody $7 D003581
650    _2
$a lidé $7 D006801
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a štítná žláza $x patologie $7 D013961
650    _2
$a nádory štítné žlázy $x patologie $7 D013964
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gabalec, F $u 4th Dept. of Internal Medicine, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.
700    1_
$a Ryska, A $u Fingerland's Department of Pathology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.
700    1_
$a Cap, J $u 4th Dept. of Internal Medicine, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.
773    0_
$w MED00009532 $t Cytopathology official journal of the British Society for Clinical Cytology $x 1365-2303 $g Roč. 26, č. 4 (2015), s. 231-7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25077794 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160725114219 $b ABA008
999    __
$a ok $b bmc $g 1155748 $s 945606
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 26 $c 4 $d 231-7 $e 20140730 $i 1365-2303 $m Cytopathology $n Cytopathology $x MED00009532
LZP    __
$a Pubmed-20160722

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...